CARLE BROMENN MEDICAL CENTER — History
CCN 140127 | 3-year financial timeline | COVID resilience: 46/100
🛡️ Public data only — no PHI permitted on this instance.
$209M
Latest Revenue (FY2022)
+9.5%
Revenue CAGR (3yr)
-10.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $175M | $177M | $209M | +18.4% | +9.5% |
| Operating Expenses | $65M | $179M | $231M | +29.0% | +89.0% |
| Operating Margin | 62.9% | -1.5% | -10.6% | -618.5% | +0.0% |
| Net Income | $110M | $-3M | $-22M | -750.4% | +0.0% |
| Licensed Beds | 206 | 206 | 206 | +0.0% | +0.0% |
| Total Patient Days | 16,117 | 33,660 | 36,857 | +9.5% | +51.2% |
| Medicare Day % | 30% | 30% | 30% | -1.6% | -0.6% |
| Medicaid Day % | 5% | 5% | 7% | +35.8% | +20.7% |
COVID Impact & Recovery
Resilience Score: 46/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +19.8% ($175M → $209M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+9.5%
This Hospital
+7.6%
State Avg
Latest Margin
-10.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $226M | -47.3% |
| FY2024 (proj) | $244M | -84.0% |
| FY2025 (proj) | $261M | -120.8% |